Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study (vol 27, pg 563, 2022)

被引：0

作者：

Kato, Renpei ^{[1
]}

Naito, Sei ^{[2
]}

Numakura, Kazuyuki ^{[3
]}

Hatakeyama, Shingo ^{[4
]}

Koguchi, Tomoyuki ^{[5
]}

Kojima, Takahiro ^{[6
]}

Kawasaki, Yoshihide ^{[7
]}

Kandori, Shuya ^{[6
]}

Kawamura, Sadafumi ^{[8
]}

Arai, Yoichi ^{[8
]}

Ito, Akihiro ^{[7
]}

Nishiyama, Hiroyuki ^{[6
]}

Kojima, Yoshiyuki ^{[5
]}

Ohyama, Chikara ^{[4
]}

Habuchi, Tomonori ^{[3
]}

Tsuchiya, Norihiko ^{[2
]}

Obara, Wataru ^{[1
]}

机构：

[1] Iwate Med Univ, Dept Urol, Sch Med, 2-1-1 Idaidori, Yahaba, Shiwa 0283695, Japan

[2] Yamagata Univ, Dept Urol, 2-2-2 Iida Nishi, Sch Med, Yamagata 9909585, Japan

[3] Akita Univ, Dept Urol, Sch Med, 1-1-1 Hondo, Akita 0108543, Japan

[4] Hirosaki Univ Grad Med, Dept Urol & Adv Blood Purificat Therapy, 5 Zaifuchou, Hirosaki 0368562, Japan

[5] Fukushima Med Univ, Dept Urol, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan

[6] Univ Tsukuba, Dept Urol, Grad Sch Med, 1-1-1 Tennodai, Tsukuba 3058575, Japan

[7] Tohoku Univ, Dept Urol, Sch Med, 2-1 Seiryo Machi,Aoba Ku, Sendai 9808575, Japan

[8] Miyagi Canc Ctr, Dept Urol, 47-1 Natori, Aijima, Natori 9811293, Japan

来源：

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 28卷 / 05期

关键词：

D O I：

10.1007/s10147-023-02331-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：726 / 727

页数：2

共 50 条

[21] The role of cytoreductive nephrectomy in elderly patients with metastatic renal cell carcinoma in an era of targeted therapy.
Uprety, Dipesh
Bista, Amir
Vallatharasu, Yazhini
Marinier, David E.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[22] Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy
Sakai, Iori
Miyake, Hideaki
Hinata, Nobuyuki
Fujisawa, Masato
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 674 - 678
[23] Prognostic significance of sarcomatoid features in metastatic renal cell carcinoma treated with cytoreductive nephrectomy and targeted therapy
Cortese, Brian D.
Chelluri, Raju
Xia, Leilei
Ostrowski, David A.
Roberson, Daniel S.
Strother, Marshall
Ding, James M.
Schwartz, Lauren
Lee, Daniel J.
Guzzo, Thomas J.
AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2022, 10 (05): : 327 - 333
[24] PROGNOSTIC SIGNIFICANCE OF SARCOMATOID FEATURES IN METASTATIC RENAL CELL CARCINOMA TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND TARGETED THERAPY
Chelluri, Raju
Xia, Leilei
Taylor, Benjamin
Raman, Jay
Guzzo, Thomas
JOURNAL OF UROLOGY, 2018, 199 (04): : E869 - E870
[25] Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study REPLY
Derweesh, Ithaar H.
Stroup, Sean P.
Millard, Frederick
UROLOGY, 2013, 81 (04) : 812 - 812
[26] Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Bakouny, Ziad
El Zarif, Talal
Dudani, Shaan
Wells, J. Connor
Gan, Chun Loo
Donskov, Frede
Shapiro, Julia
Davis, Ian D.
Parnis, Francis
Ravi, Praful
Steinharter, John A.
Agarwal, Neeraj
Alva, Ajjai
Wood, Lori
Kapoor, Anil
Morales, Jose M. Ruiz
Kollmannsberger, Christian
Beuselinck, Benoit
Xie, Wanling
Heng, Daniel Y. C.
Choueiri, Toni K.
EUROPEAN UROLOGY, 2023, 83 (02) : 145 - 151
[27] Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection? Reply
Sun, Maxine
Hanna, Nawar
Quoc-Dien Trinh
Choueiri, Toni K.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (11) : 1266 - 1267
[28] Prognostic Significance of Early Tumor Shrinkage Under Second-Line Targeted Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Study in Japan
Miyake, Hideaki
Harada, Ken-ichi
Ozono, Seiichiro
Fujisawa, Masato
MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (04) : 385 - 392
[29] Re: Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Liu, Jianliang
Moon, Daniel
Lawrentschuk, Nathan
EUROPEAN UROLOGY, 2023, 84 (02) : 244 - 245
[30] Prognostic Significance of Early Tumor Shrinkage Under Second-Line Targeted Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Study in Japan
Hideaki Miyake
Ken-ichi Harada
Seiichiro Ozono
Masato Fujisawa
Molecular Diagnosis & Therapy, 2016, 20 : 385 - 392

← 1 2 3 4 5 →